These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cloning, sequencing, and enzymatic activity of an inducible aldo-keto reductase from Chinese hamster ovary cells. Hyndman DJ; Takenoshita R; Vera NL; Pang SC; Flynn TG J Biol Chem; 1997 May; 272(20):13286-91. PubMed ID: 9148949 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of CHO reductase, a member of the aldo-keto reductase superfamily. Ye Q; Hyndman D; Li X; Flynn TG; Jia Z Proteins; 2000 Jan; 38(1):41-8. PubMed ID: 10651037 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of apolipoprotein E degradation in a post-Golgi compartment by a cysteine protease inhibitor. Ye SQ; Reardon CA; Getz GS J Biol Chem; 1993 Apr; 268(12):8497-502. PubMed ID: 8473293 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo by cysteine protease inhibitors. Inoue S; Bar-Nun S; Roitelman J; Simoni RD J Biol Chem; 1991 Jul; 266(20):13311-7. PubMed ID: 1906466 [TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of two major forms of naloxone reductase from rabbit liver cytosol, new members of aldo-keto reductase superfamily. Yamano S; Ichinose F; Todaka T; Toki S Biol Pharm Bull; 1999 Oct; 22(10):1038-46. PubMed ID: 10549852 [TBL] [Abstract][Full Text] [Related]
8. Amino acid sequence and characterization of aldo-keto reductase from bakers' yeast. Nakamura K; Kondo S; Kawai Y; Nakajima N; Ohno A Biosci Biotechnol Biochem; 1997 Feb; 61(2):375-7. PubMed ID: 9058981 [TBL] [Abstract][Full Text] [Related]
9. Comparative anatomy of the aldo-keto reductase superfamily. Jez JM; Bennett MJ; Schlegel BP; Lewis M; Penning TM Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):625-36. PubMed ID: 9307009 [TBL] [Abstract][Full Text] [Related]
10. Functional studies of aldo-keto reductases in Saccharomyces cerevisiae. Chang Q; Griest TA; Harter TM; Petrash JM Biochim Biophys Acta; 2007 Mar; 1773(3):321-9. PubMed ID: 17140678 [TBL] [Abstract][Full Text] [Related]
11. Characterization of peroxisomal 3-hydroxy-3-methylglutaryl coenzyme A reductase in UT2 cells: sterol biosynthesis, phosphorylation, degradation, and statin inhibition. Aboushadi N; Shackelford JE; Jessani N; Gentile A; Krisans SK Biochemistry; 2000 Jan; 39(1):237-47. PubMed ID: 10625499 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin-E2 9-reductase from corpus luteum of pseudopregnant rabbit is a member of the aldo-keto reductase superfamily featuring 20 alpha-hydroxysteroid dehydrogenase activity. Wintergalen N; Thole HH; Galla HJ; Schlegel W Eur J Biochem; 1995 Nov; 234(1):264-70. PubMed ID: 8529651 [TBL] [Abstract][Full Text] [Related]
13. Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms. Neumann D; Yuk MH; Lodish HF; Lederkremer GZ Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):391-9. PubMed ID: 8573070 [TBL] [Abstract][Full Text] [Related]
14. Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase. Evidence that substrate availability limits beta-amyloid peptide production. Zhang L; Song L; Parker EM J Biol Chem; 1999 Mar; 274(13):8966-72. PubMed ID: 10085142 [TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of four rabbit aldo-keto reductases featuring broad substrate specificity for xenobiotic and endogenous carbonyl compounds: relationship with multiple forms of drug ketone reductases. Endo S; Matsunaga T; Arai Y; Ikari A; Tajima K; El-Kabbani O; Yamano S; Hara A; Kitade Y Drug Metab Dispos; 2014 Apr; 42(4):803-12. PubMed ID: 24510382 [TBL] [Abstract][Full Text] [Related]
16. A new nomenclature for the aldo-keto reductase superfamily. Jez JM; Flynn TG; Penning TM Biochem Pharmacol; 1997 Sep; 54(6):639-47. PubMed ID: 9310340 [TBL] [Abstract][Full Text] [Related]
17. Methylglyoxal detoxification by an aldo-keto reductase in the cyanobacterium Synechococcus sp. PCC 7002. Xu D; Liu X; Guo C; Zhao J Microbiology (Reading); 2006 Jul; 152(Pt 7):2013-2021. PubMed ID: 16804176 [TBL] [Abstract][Full Text] [Related]
18. Relevance of aldo-keto reductase family members to the pathobiology of diabetic nephropathy and renal development. Wallner EI; Wada J; Tramonti G; Lin S; Srivastava SK; Kanwar YS Ren Fail; 2001; 23(3-4):311-20. PubMed ID: 11499547 [TBL] [Abstract][Full Text] [Related]
19. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. O'connor T; Ireland LS; Harrison DJ; Hayes JD Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318 [TBL] [Abstract][Full Text] [Related]
20. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells. Sakata N; Wu X; Dixon JL; Ginsberg HN J Biol Chem; 1993 Nov; 268(31):22967-70. PubMed ID: 8226809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]